ubmslateNT-logo-ubm

NT Mobile Menu

Search form

Topics:

Conference Report

Conference Report

What was the impact of add-on cannabidiol treatment in patients aged 2-55 years experiencing drop seizures?

You won’t want to miss these new features and sessions at this year’s American Academy of Neurology Annual Meeting, April 22-28, in Boston, MA.

Research presented at IBIA 2017 looked at risk behavior in adolescents, return to work, and maladaptive emotion regulation following TBI.

Research includes safety of digoxin with atrial fibrillation, comparison of cerebral embolic protection devices, and cerebral microbleed triggers.

Research includes a possible link between Zika & CV issues, CV effects of cannabis use, and neurocognitive impairment with PCSK9 variants.

Research examined no evidence of disease activity and no evidence of progression with ocrelizumab as well as long-term results with mitoxantrone.

Research included the impact of diet on cognitive decline and the degree of a link between depression & dementia post intracerebral hemorrhage.

Pages

Subscribe to Conference Report on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.